JPRN-UMIN000016133已完成未知
Alternation in glucagon secretion associated with progression of glucose intolerance. - Glucagon secretion and progression of glucose intolerance.
Kitasato University School of Medicine0 个研究点目标入组 53 人开始时间: 2015年1月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 53
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. A patient suffering from acute disease 2. In case of malignacy 3. Renal dysfunction (estimeted GFR <60ml/min) 4. Liver dysfunction (AST >100U/l, ALT >100U/l) 5. Pregnant or possibility of pregnant 6. Lactating mothers 7. A patient suffering from endocrine disorders 8. A patient administrated any drugs affect glucose metabolism 9. Diabetic patients who need any hypoglycemic agents 10. Fasting plasma glucose >=140mg/dl (7.8mmol/l) 11. Casual plasma glucose >=200mg/dl (11.1mmol/l) 12. Glycated hemoglobin (HbA1c) >=7.5%
研究者
相似试验
招募中
不适用
Investigation of the secretion of glucagon for glucose intoleranceormal glucose tolerance (NGT), Impaired glucose tolerance(IGT), Type 2 diabetes (T2DM)JPRN-UMIN000019252Kobe university school of medicine, Diabetes and Endocrinoplogy105
招募中
不适用
Study of glucagon response and its association with glycemic control and variability after administration of ipragliflozin as an adjunctive to insulin treatment in patients with type 1 diabetes (Suglat-AID): a single-arm, multicenter, open-label,prospective exploratory trialtype 1 diabetesJPRN-UMIN000039635agasaki University Hospital24
已完成
不适用
Alternation in glucagon secretion by dietary intake after administration of sodium glucose transporter-2 inhibitor.Type 2(non-insulin dependent) diabetes mellitusJPRN-UMIN000021977Kitasato University, School of Medicine19
已完成
不适用
Effect of the glucagon suppression ability in the sulfonylurea agents and other oral hypoglycemic agents.Type 2 diabetesJPRN-UMIN000007378Divison of Diabetes and Metabolism,Itabashi Hospital, Nihon University School of Medicine200
已完成
不适用
Comparison of glucagon levels in type-1, type-2-diabetes and healthy subjectsHealthy individualsE10.9E11.9DRKS00022061Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Klinische Abteilung für Endokrinologie und Diabetologie60